Clinical studies of GLP-1 mimetics (exenatide [91]–[96], liraglutide [97]–[102], albiglutide [103] and taspoglutide [104]) in overweight/obese patients with T2DM have demonstrated significant and durable weight losses. The gene discussed is GCG; the disease is type 2 diabetes mellitus.